797P Relapse-free Survival (RFS) Update and First Translational Analyses of DONIMI, a Study Testing Personalized Neoadjuvant Domatinostat, Nivolumab (NIVO) and Ipilimumab (IPI) in Stage III Melanoma Patients (pts) Based on the Interferon-Gamma Signature (Ifn-Γ Sign) Algorithm
ANNALS OF ONCOLOGY(2022)
Key words
Melanoma
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined